Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
12.88
-0.87 (-6.33%)
At close: Mar 27, 2026, 4:00 PM EDT
13.25
+0.37 (2.87%)
After-hours: Mar 27, 2026, 7:57 PM EDT
TNXP Market Cap
TNXP has a market cap or net worth of $172.66 million as of March 27, 2026. Its market cap has increased by 126.43% in one year.
Market Cap
172.66M
Enterprise Value
-33.67M
1-Year Change
126.43%
Ranking
Category
Stock Price
$12.88
Market Cap Chart
Since July 16, 2019, TNXP's market cap has increased from $7.29M to $172.66M, an increase of 2,267.28%. That is a compound annual growth rate of 60.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 172.66M | -10.80% |
| Dec 31, 2025 | 193.56M | 214.02% |
| Dec 31, 2024 | 61.64M | 160.94% |
| Dec 29, 2023 | 23.62M | 5.35% |
| Dec 30, 2022 | 22.42M | -87.36% |
| Dec 31, 2021 | 177.42M | 37.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MediWound | 201.64M |
| Arcturus Therapeutics Holdings | 201.24M |
| Elicio Therapeutics | 199.05M |
| Compugen | 196.20M |
| SAB Biotherapeutics | 195.14M |
| Adagene | 195.12M |
| Zentalis Pharmaceuticals | 189.39M |
| Caribou Biosciences | 184.58M |